INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

26,449 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
2,068 sh
May 6, 2026
Page 390 of 662
← PrevNext →
May 6, 2026
traded May 6, 2026
+0d
SEC Form 4

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$8,750
296 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
8,152 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

16
April McClain DelaneyDDependent child
VIKViking Holdings Ltd
Partial sale
SELL$1,001 – $15KApr 16, 2026May 6, 2026
traded Apr 16, 2026
+20dHouse PTR

Evidence

16
April McClain DelaneyDDependent child
MORNMorningstar, Inc.
Partial sale
SELL$1,001 – $15KApr 30, 2026May 6, 2026
traded Apr 30, 2026
+6dHouse PTR

Evidence

16
April McClain DelaneyDDependent child
MORNMorningstar, Inc.
Partial sale
SELL$1,001 – $15KApr 17, 2026May 6, 2026
traded Apr 17, 2026
+19dHouse PTR

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,607
325 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
April McClain DelaneyDDependent child
BROBROWN & BROWN, INC.
Partial sale
SELL$1,001 – $15KApr 17, 2026May 6, 2026
traded Apr 17, 2026
+19dHouse PTR

Evidence

16
April McClain DelaneyDDependent child
FBINFortune Brands Innovations, Inc.
Partial sale
SELL$1,001 – $15KApr 24, 2026May 6, 2026
traded Apr 24, 2026
+12dHouse PTR

Evidence

16
April McClain DelaneyDDependent child
VIKViking Holdings Ltd
Partial sale
SELL$1,001 – $15KApr 20, 2026May 6, 2026
traded Apr 20, 2026
+16dHouse PTR

Evidence

16
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$102K
2,181 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

14
WT
Watanabe ToddDirector, See Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$75K
3,172 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

14
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$1.77M
17.4K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

13
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
311 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

13
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
968 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

13
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
310 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

13
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
931 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

12
SA
Schlachet AmirDirector, CEO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$299K
9,450 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

11
VL
Vairavan LathaSVP Chief Financial Officer
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
1,341 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

11
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
884 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

11
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$764K
52.4K sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

9
OY
Ong Chin YinChief Org Capability Officer
GRABGrab Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$136K
38.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

8
LC
Liu CurtisDirector, Chief Technology Officer, 10% Owner
AMPLAmplitude, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
17.6K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

7
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$754K
7,429 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

5
FW
Fordenwalt Matthew W.SVP Lifecycle Services
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$207K
460 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

4
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$217K
2,111 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

4
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$167K
1,699 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

4
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$140K
1,408 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
4,000 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
4,000 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
4,000 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

1
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
1,065 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

1
FW
Fordenwalt Matthew W.SVP Lifecycle Services
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$63K
140 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

1
HF
Howe James F.President, Motion
GPCGENUINE PARTS CO
Open-market sale · 10b5-1 plan
SELL$43K
415 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

56
DW
Da Cunha Gustavo WerneckCEO and Board Member
GGBGERDAU S.A.
Open-market sale
SELL$396K
88.0K sh
Apr 28, 2026May 5, 2026
traded Apr 28, 2026
+7dSEC Form 4

Evidence

43
TG
Tyler Donald GDirector
GRFEAGLE CAPITAL GROWTH FUND, INC.
Open-market purchase
BUY$9,900
1,000 sh
Apr 16, 2026May 5, 2026
traded Apr 16, 2026
+19dSEC Form 4

Evidence

41
SD
Southerton DawnPrincipal Accounting Officer
JBLUJETBLUE AIRWAYS CORP
Open-market sale
SELL$91K
18.2K sh
May 4, 2026May 5, 2026
traded May 4, 2026
+1dSEC Form 4

Evidence

37
AD
Agarwal DeveshChief Operating Officer
BANDBandwidth Inc.
Open-market sale
SELL$462K
10.3K sh
May 4, 2026May 5, 2026
traded May 4, 2026
+1dSEC Form 4

Evidence

36
Kevin HernRJoint
GMGoldman Sachs MTN 4/29/2030
Sale
SELL$250K – $500KApr 29, 2026May 5, 2026
traded Apr 29, 2026
+6dHouse PTR

Evidence

35
KC
Kutsor George CChief Financial Officer
EVLVEvolv Technologies Holdings, Inc.
Open-market sale
SELL$374K
51.4K sh
May 4, 2026May 5, 2026
traded May 4, 2026
+1dSEC Form 4

Evidence